Three years ago, UCI created the Institute for Clinical and Translational Science (ICTS), which identifies tests, and implements innovative ways to break down barriers that impede biomedical discovery. In the next phase of our concerted effort to transform the UCI clinical research enterprise, our vision is to: 1) Nurture Novel Collaborations-The ICTS builds multidisciplinary research teams, such as chemists and clinicians exploring breath biomarkers in the human """"""""ventilome."""""""" ICTS experts in the science of team science will help new partnerships to identify and remove obstacles to successful collaboration before they become insurmountable. 2) Create New Technologies for Translational Science-The ICTS made novel UCI-based technologies such as biophotonics and microdevices available to a new generation of clinicians. We will now develop and provide new methodologies by partnering with UCI information scientists in the use of ubiquitous computing for field research;with nursing and social scientists for qualitative and comparative effectiveness research;and with exercise physiologists and molecular biologists for technologies that link genomic information with dynamic disease phenotypes. 3) Share Information-The ICTS has engaged clinicians, hospital IT staff, and scholars from the School of Information and Computer Sciences to create the Center for Biomedical Informatics. We are now ready to embed infrastructure for clinical data interoperability at a unique moment, namely, as UCI begins to deploy its EMR;4) Engage Our Community-The ICTS championed new approaches such as PEER (Participant Experience Enhancement in Research), a program that views research volunteers as partners in the process of discovery. We plan a range of outreach/dissemination activities, from mitigating elder abuse to preventing sudden death in pediatric athletes. And 5) Train-We will implement Crossing Boundaries, a set of degree and certificate programs along with mentorship interaction that tackles key issues in translational science. Finally, we view ourselves as part of a unique translational science network for Southern California, in which the resources of regional academic medical centers are integrated to better realize the overarching vision of the CTSA.

Public Health Relevance

(See Instructions): UCI is becoming a motivating force for clinical research in this dynamic region of Southern California. The ICTS will support a wide range of projects that will benefit public health, including the ambitious NIH-funded National Childen's Study;research into rare, poorly studied diseases of mitochondrial origin;and community outreach efforts to mitigate the health consequences of obesity among underinsured people in our region.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR000153-05S1
Application #
8917342
Study Section
Special Emphasis Panel (ZRR1-CR-3 (01))
Program Officer
Merchant, Carol
Project Start
2010-07-01
Project End
2015-03-31
Budget Start
2014-09-05
Budget End
2015-03-04
Support Year
5
Fiscal Year
2014
Total Cost
$115,875
Indirect Cost
$40,875
Name
University of California Irvine
Department
Pediatrics
Type
Schools of Medicine
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92697
Treem, Jeffrey W; Schneider, Margaret; Zender, Robynn L et al. (2018) Exploring the potential role of community engagement in evaluating clinical and translational science grant proposals. J Clin Transl Sci 2:139-146
Schneider, Margaret (2018) Intrinsic Motivation Mediates the Association Between Exercise-Associated Affect and Physical Activity Among Adolescents. Front Psychol 9:1151
Stockton, Winifred; Chen, Yanjun; Jun, Allison et al. (2018) Initial Palivizumab Dose Administration in Outpatient Clinic After Hospital Discharge. Pediatr Infect Dis J 37:1124-1129
Elahi, Asif; Sabui, Subrata; Narasappa, Nell N et al. (2018) Biotin Deficiency Induces Th1- and Th17-Mediated Proinflammatory Responses in Human CD4+ T Lymphocytes via Activation of the mTOR Signaling Pathway. J Immunol 200:2563-2570
Haas, David M; Marsh, Derek J; Dang, Danny T et al. (2018) Prescription and Other Medication Use in Pregnancy. Obstet Gynecol 131:789-798
Cassidy, Jessica M; Tran, George; Quinlan, Erin B et al. (2018) Neuroimaging Identifies Patients Most Likely to Respond to a Restorative Stroke Therapy. Stroke 49:433-438
Agrawal, Sudhanshu; Abud, Edsel M; Snigdha, Shikha et al. (2018) IgM response against amyloid-beta in aging: a potential peripheral protective mechanism. Alzheimers Res Ther 10:81
Pierce, Aimee L; Cox, Chelsea G; Nguyen, Huong T et al. (2018) Participant Satisfaction With Learning Alzheimer Disease Clinical Trial Results. Alzheimer Dis Assoc Disord 32:366-368
Nakahara, Soichiro; Medland, Sarah; Turner, Jessica A et al. (2018) Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia. Schizophr Res 201:393-399
Henry, Shayna L; Jamner, Larry D; Choi, Sarah E et al. (2018) The effect of the interdialytic interval on cognitive function in patients on haemodialysis. J Ren Care 44:44-51

Showing the most recent 10 out of 248 publications